COGENTIX MEDICAL, INC. (NASDAQ:CGNT) Files An 8-K Submission of Matters to a Vote of Security Holders

ME Staff 8-k

7 years ago

COGENTIX MEDICAL, INC. (NASDAQ:CGNT) Files An 8-K Submission of Matters to a Vote of Security Holders

Item 5.07.

Submission of Matters to a Vote of Security Holders.

On June 5, 2017, Cogentix Medical, Inc. (the Company) held
its 2017 Annual Meeting of Stockholders (the Annual
Meeting). We have disclosed the final voting results for each
proposal presented at the Annual Meeting:

1. Proposal to elect three (3) director nominees, Cheryl Pegus,
Kenneth Samet and Nachum Shamir, to the Board of Directors of the
Company. The director nominees were elected by a plurality of the
votes cast:

	FOR	WITHHOLD	BROKER NON-VOTE
Cheryl Pegus	45,837,760	1,070,212	11,695,012
Kenneth Samet	46,663,695	244,277	11,695,012
Nachum Shamir	46,590,663	317,309	11,695,012

2. Proposal to approve the amendment and restatement of the
Companys Certificate of Incorporation and the amendment and
restatement of the Companys Bylaws to declassify the Board of
Directors, and to make related changes, effective immediately
after the Annual Meeting. The proposal was approved by 77.1% of
the votes which all of the stockholders would be entitled to cast
at the Annual Meeting.

Since stockholders approved this Proposal, the directors named in
the prior Proposal, and all directors going forward, will be
elected annually and until their successors are duly elected and
qualified.

FOR	AGAINST	ABSTAIN	BROKER NON-VOTE
46,602,174	280,521	25,277	11,695,012

3. Proposal to ratify the selection of Grant Thornton LLP as the
Companys independent registered public accounting firm for the
year ending December 31, 2017. The proposal was approved by 99.7%
of the shares of common stock voting on the matter.

FOR	AGAINST	ABSTAIN	BROKER NON-VOTE
58,444,542	62,683	95,759

There were no other matters voted upon at the Annual Meeting. The
Company withdrew Proposal No. 3 (to approve the amendment and
restatement of the Companys Certificate of Incorporation and the
amendment and restatement of the Companys Bylaws to eliminate the
requirement that stockholder written consents must be unanimous)
immediately prior to the Annual Meeting.

About COGENTIX MEDICAL, INC. (NASDAQ:CGNT)
Cogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). The Company also offers Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency. The PrimeSight flexible endoscopes are used in conjunction with the sterile, single-use microbial barrier known as the EndoSheath Protective Barrier. The PrimeSight endoscopy line also includes rigid endoscopes and portable peripherals, such as the video system and stroboscopy unit.